Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4028888017 | Product containing tafasitamab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4028889013 | Tafasitamab-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4865071000052113 | läkemedel som innehåller tafasitamab, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing tafasitamab in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing tafasitamab in parenteral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Product containing tafasitamab in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Product containing tafasitamab in parenteral dose form (medicinal product form) | Is a | Tafasitamab-containing product | true | Inferred relationship | Some | ||
| Product containing tafasitamab in parenteral dose form (medicinal product form) | Has active ingredient | Tafasitamab (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only tafasitamab in parenteral dose form (medicinal product form) | Is a | True | Product containing tafasitamab in parenteral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR